With a $157 million series C funding round, Hemab Therapeutics is looking to infuse innovation into the treatment landscape ...
Activation of the complement cascade of proteases has been linked to autoimmune and kidney diseases, including systemic lupus ...
An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...